GlassScriptPhysician profile
Heather M Amos
NPI 1962672584
$557.52
in general payments reported to CMS, 2019-2025
9 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.09 · 2022: $42.98 · 2023: $77.13 · 2024: $170 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $159.98 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Lilly USA, LLC | $132.17 | 2024-2025 | Mounjaro, Zepbound, Kisunla |
| Pfizer INC. | $87.95 | 2024-2025 | |
| Exact Sciences Corporation | $58.57 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $33.94 | 2025 | Breztri, Airsupra |
| Novo Nordisk INC | $33.92 | 2020-2025 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $23.38 | 2024 | Rexulti |
| Amgen INC. | $13.81 | 2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $13.80 | 2025 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Amos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.